DVHGF
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
HMTXF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Oct 4 closing price
Ad is loading...

DVHGF vs HMTXF

Header iconDVHGF vs HMTXF Comparison
Open Charts DVHGF vs HMTXFBanner chart's image
Devonian Health Group
Price$0.10
Change-$0.00 (-0.00%)
Volume$5K
CapitalizationN/A
Hemostemix
Price$0.05
Change-$0.00 (-0.00%)
Volume$60.7K
CapitalizationN/A
View a ticker or compare two or three
DVHGF vs HMTXF Comparison Chart
Loading...
VS
DVHGF vs. HMTXF commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVHGF is a Hold and HMTXF is a Buy.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (DVHGF: $0.11 vs. HMTXF: $0.04)
Brand notoriety: DVHGF and HMTXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DVHGF: 20% vs. HMTXF: 26%
Market capitalization -- DVHGF: $14.82M vs. HMTXF: $6.46M
DVHGF [@Biotechnology] is valued at $14.82M. HMTXF’s [@Biotechnology] market capitalization is $6.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DVHGF’s FA Score shows that 1 FA rating(s) are green whileHMTXF’s FA Score has 1 green FA rating(s).

  • DVHGF’s FA Score: 1 green, 4 red.
  • HMTXF’s FA Score: 1 green, 4 red.
According to our system of comparison, both DVHGF and HMTXF are a bad buy in the long-term.

Price Growth

DVHGF (@Biotechnology) experienced а +10.40% price change this week, while HMTXF (@Biotechnology) price change was -10.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
DVHGF($14.8M) has a higher market cap than HMTXF($6.46M). HMTXF YTD gains are higher at: -13.219 vs. DVHGF (-48.363).
DVHGFHMTXFDVHGF / HMTXF
Capitalization14.8M6.46M229%
EBITDA-2.32MN/A-
Gain YTD-48.363-13.219366%
P/E RatioN/AN/A-
Revenue9.75MN/A-
Total Cash3.51MN/A-
Total Debt2.18MN/A-
FUNDAMENTALS RATINGS
HMTXF: Fundamental Ratings
HMTXF
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME21.660.39
+1.83%
GameStop Corp
BTC.X67612.720000571.609400
+0.85%
Bitcoin cryptocurrency
TSLA221.331.76
+0.80%
Tesla
SPY582.302.52
+0.43%
SPDR® S&P 500® ETF Trust
AAPL231.78-2.07
-0.89%
Apple

DVHGF and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVHGF has been loosely correlated with CSPHF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if DVHGF jumps, then CSPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVHGF
1D Price
Change %
DVHGF100%
N/A
CSPHF - DVHGF
40%
Loosely correlated
N/A
WINT - DVHGF
38%
Loosely correlated
+4.70%
JAGX - DVHGF
27%
Poorly correlated
+6.03%
RNAZ - DVHGF
25%
Poorly correlated
-8.11%
HMTXF - DVHGF
21%
Poorly correlated
-4.44%
More

HMTXF and

Correlation & Price change

A.I.dvisor tells us that HMTXF and DMAC have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HMTXF and DMAC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HMTXF
1D Price
Change %
HMTXF100%
-4.44%
DMAC - HMTXF
22%
Poorly correlated
-1.12%
AGEN - HMTXF
21%
Poorly correlated
+0.43%
DVHGF - HMTXF
21%
Poorly correlated
N/A
FDMT - HMTXF
13%
Poorly correlated
-2.59%
ZVRA - HMTXF
9%
Poorly correlated
+0.95%
More